Cyclic AMP antagonizes adenosine-induced inhibition of ganglionic transmission

Brain Research

Volumn 787, Issue 2, 1998, Pages 242-247

  Hogan, Yvonne H ^a   Florent, Germaine ^a   Hussain, Tahir ^b   Alkadhi, Karim A ^b  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Adenylate cyclase inhibitor; Arginine vasopressin; Forskolin; Imidazole; Papaverine; Phosphodiesterase activator; Phosphodiesterase inhibitor; Superior cervical ganglion

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 8 BROMO CYCLIC AMP; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE; ARGIPRESSIN; CYCLIC AMP; FORSKOLIN; IMIDAZOLE DERIVATIVE; ISOPRENALINE; PAPAVERINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERIOR CERVICAL GANGLION; SYNAPTIC INHIBITION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADENOSINE; ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ANIMALS; CYCLIC AMP; ENZYME ACTIVATION; ENZYME INHIBITORS; GANGLIONIC BLOCKERS; MALE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SUPERIOR CERVICAL GANGLION; SYNAPTIC TRANSMISSION; VASOPRESSINS;

EID: 0032559874     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01497-2     Document Type: Article

References (24)

1. Alkadhi K.A., Brown T.R., Sabouni M.H. Inhibitory effect of adenosine on transmission in sympathetic ganglia. Naunyn-Schmiedeberg's Arch. Pharmacol. 328:1984;16-19.
2. Alkadhi K.A., Simples J.E. Effects of inorganic potassium channel blockers on calcium requirement of transmission in a sympathetic ganglion. J. Auton. Nerv. Syst. 34:1991;221-230.
3. 1 receptors by dopamine or fenoldopam increases cAMP levels in the renal artery but not in the superior cervical ganglion of the rat. J. Pharmacol. Exp. Ther. 238:1986;547-553.
4. Bennett M.R., Ho S. Probabilistic secretion of quanta from nerve terminals in avian ciliary ganglia modulated by adenosine. J. Physiol. 440:1991;513-527.
5. Borasio P.G., Pavan B., Fabbri E., Ginannicorradini F., Arcelli D., Poli A. Adenosine analogs inhibit acetylcholine release and cyclic AMP synthesis in the guinea-pig superior cervical ganglion. Neurosci. Lett. 184:1995;97-100.
6. Briggs C.A., McAfee D.A., McCaman R.E. Long-term regulation of synaptic acetylcholine release and nicotinic transmission: the role of cAMP. Br. J. Pharmacol. 93:1988;399-411.
7. Brown D.A., Dunn P.M. Cyclic adenosine 3′,5′-mono-phosphate and β-effects in rat isolated superior cervical ganglia. Br. J. Pharmacol. 79:1983;441-449.
8. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
9. Fredholm B.B. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76:1995;186-193.
10. Fredholm B.B., Fastbom M.J., Lindgren E. Effects of N-ethylmaliemide and forskolin on glutamate release from rat hippocampal slices: evidence that prejunctional adenosine receptors are linked to N-protein but not adenylate cyclase. Acta Physiol. Scand. 127:1986;381-386.
11. 2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase. Mol. Pharmacol. 41:1992;352-359.
12. 3 adenosine receptors. Med. Chem. 38:1995;1720-1735.
13. Kamiya H. Some pharmacological differences between hippocampal excitatory and inhibitory synapses in transmitter release; an in vitro study. Synapse. 8:1991;229-235.
14. Larkum L.E., Warren D., Bennett M. Calcium concentration changes in the calyciform nerve terminal of the avian ciliary ganglion during long-term potentiation. J. Auton. Nerv. Syst. 46:1994;175-188.
15. Madison D.V., Fox A.P., Tsien R.W. Adenosine reduces an inactivating component of calcium current in hippocampal CA3 neurons. Biophys. J. 51:1987;30-39.
16. Quenzer L., Yahn D., Alkadhi K.A., Volle R.L. Transmission blockade and stimulation of ganglionic adenylate cyclase by catecholamines. J. Pharmacol. Exp. Ther. 208:1979;31-36.
17. Scholz K.P., Miller R.J. Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses. Neuron. 8:1992;1139-1150.
18. Seamon K.B., Daly J.W. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7:1981;201-224.
19. Sebastiao A.M., Ribeiro J.A. 1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction. Br. J. Pharmacol. 96:1989;211-219.
20. Stone T.W. Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system. Neuroscience. 6:1981;523-555.
21. Trussell L.O., Jackson M.B. Dependence of an adenosine-activated potassium current on GTP-binding protein in mammalian central neurons. J. Neurosci. 7:1987;3306-3316.
22. Xia Y., Fertel R.H., Wood J.D. Suppression of cAMP formation by adenosine in myenteric ganglia from guinea-pig small intestine. Eur. J. Pharmacol. 320:1997;95-101.
23. Yamamoto C., Sawada S., Ohno-Shosaku T. Quantal analysis of modulating action of adenosine on the mossy fiber synapse in hippocampal slices. Hippocampus. 3:1993;87-92.
24. 2+ channels by adenosine autoreceptors. Nature. 365:1993;256-258.